透過您的圖書館登入
IP:3.136.22.50
  • 期刊

Lupus Erythematosus Like Skin Lesions Induced by Tegafur-Uracil - A Case Report -

Tegafur-Uracil 引起之類似紅斑性狼瘡的皮膚病灶-病例報告-

摘要


UFUR為一種綜合了uracll 和tegafur 這兩種藥物的第2抗癌藥。少數的皮膚疾病與接受UFUR的治療有關。本篇報告一例69歲罹患胃癌男性病患服用UFUR大約兩周時,出現類似紅斑性狼瘡的皮膚病灶。而根據發現有典型皮膚紅斑性狼瘡的組織病理特徵,以及有陽性反應的抗核抗體(包括點狀和核仁型態),以及抗Ro和抗La抗體,診斷為藥物所引發的紅斑性狼瘡。皮膚病灶停藥並接受類固醇治療後,約兩周內緩解。但再次給藥時又再度地復發。這是台灣首例報告因服用UFUR引發類似紅斑性狼瘡的皮膚病灶。UFUR應被列為在接受治療時,會引發類似紅斑性狼瘡病灶可能的原因。(中華皮誌22 : 173-177 , 2004 )

關鍵字

無資料

並列摘要


Tegafhr-Uracil (UFUR) is a second generation anticancer agent. Few skin lesions are associated with UFUR therapy. Skin lesions with features of lupus erythematosus occurred in a 69-year-old man after starting UFUR treatment for 2 weeks for gastric adenocarcinoma. The diagnosis of drug-induced lupus erythematosus was supported by classic histopathologic findings of cutaneous lupus erythematosus, positive antinuclear(speckled and nucleolar pattem), and anti-SSA/Ro and SSB/La antibodies. The skin lesions resolved within 2 weeks after discontinuation of UFUR and treatment with steroids, but recurred on readministration of UFUR. This may be the first reported case of UFUR- induced lupus erythematosus-like skin lesions in Taiwan. UFUR should be considered as a possible cause of lupus erythematosus-like skin lesions during UFUR therapy. (Dermatol Sinica 22: 173-177, 2004)

延伸閱讀